Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses.
Nuhn L, De Koker S, Van Lint S, Zhong Z, Catani JP, Combes F, Deswarte K, Li Y, Lambrecht BN, Lienenklaus S, Sanders NN, David SA, Tavernier J, De Geest BG.
Nuhn L, et al. Among authors: de geest bg, de koker s.
Adv Mater. 2018 Nov;30(45):e1803397. doi: 10.1002/adma.201803397. Epub 2018 Oct 1.
Adv Mater. 2018.
PMID: 30276880